- Report
- December 2022
- 105 Pages
North America
From €3079EUR$3,450USD£2,668GBP
- Report
- December 2022
- 117 Pages
Asia Pacific
From €3079EUR$3,450USD£2,668GBP
- Report
- October 2022
- 181 Pages
Global
From €3972EUR$4,450USD£3,442GBP
- Report
- December 2020
- 211 Pages
Global
From €3972EUR$4,450USD£3,442GBP
- Report
- March 2025
- 290 Pages
Global
From €4008EUR$4,490USD£3,473GBP
From €4418EUR$4,950USD£3,828GBP
- Report
- August 2024
Global
From €2187EUR$2,450USD£1,895GBP
- Report
- June 2024
Global
From €4418EUR$4,950USD£3,828GBP
- Report
- December 2023
- 102 Pages
Global
From €4418EUR$4,950USD£3,828GBP
- Report
- November 2023
- 66 Pages
Global
From €2187EUR$2,450USD£1,895GBP
- Report
- November 2022
- 63 Pages
Global
From €4418EUR$4,950USD£3,828GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1785EUR$2,000USD£1,547GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1116EUR$1,250USD£967GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1339EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1785EUR$2,000USD£1,547GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1785EUR$2,000USD£1,547GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1785EUR$2,000USD£1,547GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1116EUR$1,250USD£967GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1339EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1339EUR$1,500USD£1,160GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more